{
    "title": "114_s799",
    "content": "The \"Protecting Our Infants Act of 2015\" addresses problems related to prenatal opioid use by conducting a review of planning and coordination within the Department of Health and Human Services. The Secretary is tasked with developing a strategy to address gaps in research and Federal program coordination, specifically focusing on the treatment of pregnant women with opioid use disorders. The \"Protecting Our Infants Act of 2015\" requires the Secretary to review and address gaps in the treatment of opioid use disorders in pregnant women, neonatal abstinence syndrome in infants, and coordination of Federal efforts in education and prevention. A report must be submitted to the Senate and Health, Education, Labor, and Pensions Committee within one year of enactment. The Secretary is required to conduct a study and develop recommendations for preventing and treating prenatal opioid use disorders, considering previous epidemics and seeking input from various entities. The Secretary will make recommendations on preventing and treating prenatal opioid use disorders, involving input from various entities, including recognized Indian tribes, organizations representing patients and healthcare providers. A report will be available online within 18 months, addressing key issues related to neonatal abstinence syndrome research. The outcomes of neonatal abstinence syndrome, including identifying and treating pregnant women or women at risk of opioid use disorders, evaluating causes and barriers to treatment among women of reproductive age, current healthcare practices for pregnant women with opioid use disorders, medically indicated opioid use during pregnancy, and access to treatment for pregnant and postpartum women. The text discusses recommendations for preventing, identifying, and treating prenatal opioid use effects on infants, treating pregnant women with opioid use disorders, preventing opioid use disorders in women of reproductive age, and reducing disparities in opioid use disorders among pregnant women. It also mentions improving data and the public health response through technical assistance to support States. The text discusses recommendations for preventing, identifying, and treating prenatal opioid use effects on infants, treating pregnant women with opioid use disorders, preventing opioid use disorders in women of reproductive age, and reducing disparities in opioid use disorders among pregnant women. It also mentions providing technical assistance to support States and Federally recognized Indian Tribes in collecting information on neonatal abstinence syndrome and implementing public health measures to educate the public and healthcare providers. The curr_chunk discusses the roles of the Speaker of the House of Representatives and the Vice President of the United States as President of the Senate."
}